Finance

Beta
Lists
ORY:BME
Oryzon Genomics SA
€3.03
-1.56%
(-0.048) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ORY...
Open
€3.08
High
€3.10
Low
€3.03
Mkt. cap
246.88M
Avg. vol.
381.98K
Volume
226.35K
52-wk high
€4.02
52-wk low
€2.56
EPS
-€0.03
Shares outstanding
79.89M
No. of employees
46
Open
€3.08
High
€3.10
Low
€3.03
Mkt. cap
246.88M
Avg. vol.
381.98K
Volume
226.35K
52-wk high
€4.02
52-wk low
€2.56
EPS
-€0.03
Shares outstanding
79.89M
No. of employees
46
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to ORY in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ORY in the last 3 months.
Highest
Current €3.03
€8.61 (+184.12%)
Average
€6.40 (+111.22%)
Lowest
€4.20 (+38.61%)
News stories
From sources across the web
About Oryzon Genomics SA
CEOCarlos Buesa
Employees46
Founded2000
Headquarters-
SectorBiotechnology
Websiteoryzon.com
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (EUR)
-€0.02 / -€0.04
+59.21%beat
Revenue / Est. (EUR)
- / 2.00M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
4.22M
-
10.93M
Cost of goods sold
-
147.25K
-
282.49K
Cost of revenue
-
147.25K
-
282.49K
Research and development expenses
-
-2.20M
-
-8.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1.45M
-
480.49K
Operating expense
-
3.81M
-
4.85M
Total operating expenses
-
3.95M
-
5.14M
Operating income
-
265.77K
-
5.80M
Other non operating income
-
-1.89M
-
-8.22M
EBT including unusual items
-
-1.31M
-
-4.34M
EBT excluding unusual items
-
-1.31M
-
-4.34M
Income tax expense
-
-1.28M
-
-2.99M
Effective tax rate
-
97.62%
-
68.94%
Other operating expenses
-
4.48M
-
12.44M
Net income
-
-31.27K
-
-1.35M
Net profit margin
-
-0.74%
-
-12.33%
Earnings per share
-0.03
-
0.01
-0.02
Interest and investment income
-
380.08K
-
-
Interest expense
-
-121.42K
-
-1.98M
Net interest expenses
-
258.66K
-
-1.98M
Depreciation and amortization charges
-
70.05K
-
133.91K
EBITDA
-
296.28K
-
5.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer